[HTML][HTML] Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - BMC cancer, 2020 - Springer
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - BMC Cancer, 2020 - go.gale.com
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
[HTML][HTML] Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder… - BMC …, 2020 - bmccancer.biomedcentral.com
Quiescent tumor cells pose a major clinical challenge due to their ability to resist
conventional chemotherapies and to drive tumor recurrence. Understanding the molecular …
conventional chemotherapies and to drive tumor recurrence. Understanding the molecular …
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - BMC Cancer, 2020 - europepmc.org
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
[PDF][PDF] Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - 2020 - scholar.archive.org
Background: Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
[PDF][PDF] Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - 2020 - academia.edu
Background: Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox, K Datta… - BMC Cancer, 2020 - hero.epa.gov
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
Tumor quiescence: Elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox… - BMC …, 2020 - experts.nebraska.edu
Background: Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
EP Metz, EL Wuebben, PJ Wilder, JL Cox… - BMC …, 2020 - search.proquest.com
Background Quiescent tumor cells pose a major clinical challenge due to their ability to
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …
resist conventional chemotherapies and to drive tumor recurrence. Understanding the …